Korean journal of dermatology (대한피부과학회지)

Korean Dermatological Association (대한피부과학회)
권호 표지

Treatment of Malignant Melanoma Using Sentinel Lymph Node Dissection

전초림프절 절제술을 이용한 악성흑색종의 치료

Kim, Chul-Woo;Huh, Dong;Lee, Chong-Ju
김철우;허동;이종주

  • Published : 20030100
⟨ Previous Next ⟩

Abstract

Background : Sentinel lymph node dissection is a new therapeutic strategy of malignant melanoma. There was no clinical study about sentinel lymph node dissection in Korea. Objective : Our purpose was to analyze the results of the treatment of malignant melanoma using sentinel lymph node dissection and to compare sentinel lymph node dissection with elective lymph node dissection. Methods : History of 9 cases with malignant melanoma(1 case treated with elective lymph node dissection and 8 cases treated with sentinel lymph node dissection) at our institution over 2 years were reviewed. We evaluated the clinical & histopathologic data, status of sentinel lymph node and results of treatment. Results: 1. Sentinel lymph nodes were located within the regional lymph node basins in all 8 cases of extremity melanoma, except 1 case(trunk melanoma). 2. Of 8 cases treated with sentinel lymph node dissection, the number of sentinel lymph node was 11, and positive lymph nodes was 3. 3. Patients with positive sentinel lymph node were treated with therapeutic regional lymphadenectomy, chemotherapy and adjuvant therapy. No further treatment or only interferon administration was done in patients with negative sentinel lymph node. Conclusion: We confirmed the usefulness of lymphoscintigraphy and sentinel lymph node dissection using vital dye staining in the diagnosis and treatment of lymph node metastasis of melanoma. (Korean J Dermatol 2003;41(1) : 58-64)

Keywords

References

  1. Morton DL, Wcn DR, Wong JH, Economou JS, Caglc LA, Storm K, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:391-401
  2. Reintgen DS, Cruse CW, Berman C, Ross M, Rappaport D, Glass F, et al. An orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-767 https://doi.org/10.1097/00000658-199412000-00009
  3. Bostick PJ, Giuliano AE. Vital dyes in sentinel node localization. Semin Nucl Med 2000;30: 18-24 https://doi.org/10.1016/S0001-2998(00)80058-6
  4. 김철우，김영진，김수영，허동，이종주. 전초림프절(Sentinel node)의 현미경적 전이가 확인된 악성흑색종 2예. 대피지 2001;39: 1293-1297
  5. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American joint committee on cancer staging system for cutaneous Melanoma. J Clin Oncol 2001;19:3635-3648 https://doi.org/10.1200/JCO.2001.19.16.3635
  6. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal-access surgery for staging of malignant melanoma. Arch Sug 1995;130:654-660 https://doi.org/10.1001/archsurg.1995.01430060092018
  7. Bostick P, Essner R, Glass E, Kelley M, Sarantou T, Foshag LJ, et al. Comparison of blue dye and probeassisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins. Arch Surg 1999; 134:43-49 https://doi.org/10.1001/archsurg.134.1.43
  8. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238-1241 https://doi.org/10.1007/BF00801606
  9. Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al. Efficacy of an elective regional lymph node dissection of 1 to 4mm thick melanomas for patients 60 years of age and younger. Ann Surgery 1996;224:255-263;discussion 263-266
  10. Reintgen DS, Einstein A. The role of research in cost containment. Cancer Control Journal Moffitt Cancer Center 1995;2:429
  11. Essner R, Conforti A, Kelley MC, Wanek L, Stern S, Glass E, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999;6:442-449 https://doi.org/10.1007/s10434-999-0442-4
  12. McCready DR, Ghazarian DM, Hershkop MS, Walker JA, Ambus U, Quirt IC. Sentinel lymph-node biopsy after previous wide local excision for melanoma. Can J Surg 2001;44:432-434
  13. Jones RR, Acland K. Sentinel node biopsy in the management of malignant melanoma. Clin Exp Dermatol 2001;26:463-468 https://doi.org/10.1046/j.1365-2230.2001.00868.x
  14. Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, et al. Comparison of PET scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 2001;19:2674-2678 https://doi.org/10.1200/JCO.2001.19.10.2674
  15. Wagner JD, Corbett L, Park HM, Davidson D, Coleman JJ, Havlik RJ, et al. Sentinel lymph node biopsy for melanoma. Experience with 234 consecutive procedures Plast Reconst Surg 2000;105:1956-1966 https://doi.org/10.1097/00006534-200005000-00007
  16. Balch CM, Buzaid AC, Atkins MB, Cascinel1i N, Coit DG, Fleming ID, et al. A new American Joint Committee on Cancer Staging System for Cutaneous Melanoma. Cancer 2000;88:1484-1491 https://doi.org/10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D
  17. Sumner W, Ross M, Prieto V, Mansfield P, Lee J, Schacherer C, et al. Patterns of failure in patients with thick(>4mm) melanoma undergoing sentinel node biopsy. Melanoma Res 2001;11(Suppl 1):S109-S110
  18. Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, et al. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol 2001;44:762-766 https://doi.org/10.1067/mjd.2001.112346
  19. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;3:976-983
  20. Bongers V, Borel Rinkes IH, Barneveld PC, Canningavan Dijk MR, van Rijk PP, van Vloten WA. Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a european survey. Eur J Nucl Med 1999;26: 84-90 https://doi.org/10.1007/s002590050363
  21. Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, et al. The progression of melanoma nodal metastases is dependent on tumour thickness of the primary lesion. Ann Surg Oncol 1999;6: 144-149 https://doi.org/10.1007/s10434-999-0144-y
  22. Thompson JF. Surgical management of occult lymph node metastases. Melanoma Res 2001;11(Suppl 1):SI2